27430240|t|Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice
27430240|a|The number of regulatory T cells (Treg cells) and the expression of ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1; also known as CD39) and 5'-ectonucleotidase (NT5E; also known as CD73) on the Treg cell surface are increased during sepsis. In this study, to determine the factors leading to the high expression of CD39 and CD73, and the regulation of the CD39 / CD73 / adenosine pathway in Treg cells under septic conditions, we constructed a mouse model of sepsis and separated the Treg cells using a flow cytometer. The Treg cells isolated from the peritoneal lavage and splenocytes of the mice were treated with adenosine or the specific adenosine A2A receptor agonist, CGS21680, and were transfected with specific siRNA targeting E2F transcription factor 1 (E2F-1) or cyclic adenosine monophosphate (cAMP) response element-binding protein (CREB), which are predicted transcription regulatory factors of CD39 or CD73. The regulatory relationships among these factors were then determined by western blot analysis and dual-luciferase reporter assay. In addition, changes in adenosine metabolism were measured in the treated cells. The results revealed that adenosine and CGS21680 significantly upregulated CD39 and CD73 expression (P<0.01). E2F-1 and CREB induced CD39 and CD73 expression, and were upregulated by adenosine and CGS21680. Adenosine triphosphate (ATP) hydrolysis and adenosine generation were inhibited by the knockdown of E2F-1 or CREB, and were accelerated in the presence of CGS21680. Based on these results, it can be inferred that adenosine, the adenosine A2A receptor agonist, E2F-1 and CREB are the possible factors contributing to the high expression of CD39 and CD73 on the Treg cell surface during sepsis. Adenosine and its A2A receptor agonist served as the signal transducer factors of the CD39 / CD73 / adenosine pathway, accelerating adenosine generation. Our study may benefit further research on adenosine metabolism for the treatment of sepsis.
27430240	0	9	Adenosine	T114,T121,T123	C0001443
27430240	18	48	adenosine A2A receptor agonist	T121	C2936552
27430240	50	58	CGS21680	T109,T121	C0055233
27430240	60	70	upregulate	T044	C0949479
27430240	71	75	CD39	T129	C0108783
27430240	80	84	CD73	T116,T126,T129	C0000530
27430240	85	95	expression	T045	C0597360
27430240	104	109	E2F-1	T116,T123	C1384539
27430240	114	118	CREB	T116,T123	C0056695
27430240	122	140	regulatory T cells	T025	C0039198
27430240	141	149	isolated	T169	C0205409
27430240	155	161	septic	T169	C0333534
27430240	162	166	mice	T015	C0025929
27430240	181	199	regulatory T cells	T025	C0039198
27430240	201	211	Treg cells	T025	C0039198
27430240	221	231	expression	T045	C0597360
27430240	235	283	ectonucleoside triphosphate diphosphohydrolase 1	T129	C0108783
27430240	285	291	ENTPD1	T129	C0108783
27430240	307	311	CD39	T129	C0108783
27430240	317	336	5'-ectonucleotidase	T116,T126,T129	C0000530
27430240	338	342	NT5E	T116,T126,T129	C0000530
27430240	358	362	CD73	T116,T126,T129	C0000530
27430240	371	380	Treg cell	T025	C0039198
27430240	381	388	surface	T082	C0205148
27430240	393	402	increased	T081	C0205217
27430240	410	416	sepsis	T047	C0243026
27430240	450	457	factors	T123	C0005515
27430240	473	477	high	T080	C0205250
27430240	478	488	expression	T045	C0597360
27430240	492	496	CD39	T129	C0108783
27430240	501	505	CD73	T116,T126,T129	C0000530
27430240	515	528	regulation of	T038	C1327622
27430240	533	537	CD39	T129	C0108783
27430240	540	544	CD73	T116,T126,T129	C0000530
27430240	547	556	adenosine	T114,T121,T123	C0001443
27430240	557	564	pathway	T077	C1705987
27430240	568	578	Treg cells	T025	C0039198
27430240	585	591	septic	T169	C0333534
27430240	621	632	mouse model	T050	C2986594
27430240	636	642	sepsis	T047	C0243026
27430240	661	671	Treg cells	T025	C0039198
27430240	680	694	flow cytometer	T074	C0180279
27430240	700	710	Treg cells	T025	C0039198
27430240	711	719	isolated	T169	C0205409
27430240	729	746	peritoneal lavage	T058	C0031148
27430240	751	762	splenocytes	T025	C1519477
27430240	770	774	mice	T015	C0025929
27430240	780	792	treated with	T061	C0332293
27430240	793	802	adenosine	T114,T121,T123	C0001443
27430240	819	849	adenosine A2A receptor agonist	T121	C2936552
27430240	851	859	CGS21680	T109,T121	C0055233
27430240	870	881	transfected	T063	C0040669
27430240	896	901	siRNA	T114,T123	C1099354
27430240	902	911	targeting	T169	C1521840
27430240	912	938	E2F transcription factor 1	T116,T123	C1384539
27430240	940	945	E2F-1	T116,T123	C1384539
27430240	950	1020	cyclic adenosine monophosphate (cAMP) response element-binding protein	T116,T123	C0056695
27430240	1022	1026	CREB	T116,T123	C0056695
27430240	1049	1081	transcription regulatory factors	T116,T123	C0040648
27430240	1085	1089	CD39	T129	C0108783
27430240	1093	1097	CD73	T116,T126,T129	C0000530
27430240	1103	1113	regulatory	T038	C1327622
27430240	1140	1147	factors	T123	C0005515
27430240	1172	1193	western blot analysis	T059	C0949466
27430240	1198	1228	dual-luciferase reporter assay	T059	C0022885
27430240	1243	1250	changes	T169	C0392747
27430240	1254	1274	adenosine metabolism	T044	C1158592
27430240	1296	1303	treated	T169	C1522326
27430240	1304	1309	cells	T025	C0007634
27430240	1337	1346	adenosine	T114,T121,T123	C0001443
27430240	1351	1359	CGS21680	T109,T121	C0055233
27430240	1374	1385	upregulated	T044	C0949479
27430240	1386	1390	CD39	T129	C0108783
27430240	1395	1399	CD73	T116,T126,T129	C0000530
27430240	1400	1410	expression	T045	C0597360
27430240	1421	1426	E2F-1	T116,T123	C1384539
27430240	1431	1435	CREB	T116,T123	C0056695
27430240	1444	1448	CD39	T129	C0108783
27430240	1453	1457	CD73	T116,T126,T129	C0000530
27430240	1458	1468	expression	T045	C0597360
27430240	1479	1490	upregulated	T044	C0949479
27430240	1494	1503	adenosine	T114,T121,T123	C0001443
27430240	1508	1516	CGS21680	T109,T121	C0055233
27430240	1518	1557	Adenosine triphosphate (ATP) hydrolysis	T044	C1510699
27430240	1562	1571	adenosine	T114,T121,T123	C0001443
27430240	1572	1582	generation	T052	C3146294
27430240	1588	1597	inhibited	T052	C3463820
27430240	1605	1614	knockdown	T080	C0849355
27430240	1618	1623	E2F-1	T116,T123	C1384539
27430240	1627	1631	CREB	T116,T123	C0056695
27430240	1642	1653	accelerated	T169	C0521110
27430240	1673	1681	CGS21680	T109,T121	C0055233
27430240	1731	1740	adenosine	T114,T121,T123	C0001443
27430240	1746	1776	adenosine A2A receptor agonist	T121	C2936552
27430240	1778	1783	E2F-1	T116,T123	C1384539
27430240	1788	1792	CREB	T116,T123	C0056695
27430240	1810	1817	factors	T123	C0005515
27430240	1838	1842	high	T080	C0205250
27430240	1843	1853	expression	T045	C0597360
27430240	1857	1861	CD39	T129	C0108783
27430240	1866	1870	CD73	T116,T126,T129	C0000530
27430240	1878	1887	Treg cell	T025	C0039198
27430240	1888	1895	surface	T082	C0205148
27430240	1903	1909	sepsis	T047	C0243026
27430240	1911	1920	Adenosine	T114,T121,T123	C0001443
27430240	1929	1949	A2A receptor agonist	T121	C2936552
27430240	1964	1981	signal transducer	T044	C1152628
27430240	1982	1989	factors	T123	C0005515
27430240	1997	2001	CD39	T129	C0108783
27430240	2004	2008	CD73	T116,T126,T129	C0000530
27430240	2011	2020	adenosine	T114,T121,T123	C0001443
27430240	2021	2028	pathway	T077	C1705987
27430240	2030	2042	accelerating	T169	C0521110
27430240	2043	2052	adenosine	T114,T121,T123	C0001443
27430240	2053	2063	generation	T052	C3146294
27430240	2095	2103	research	T062	C0035168
27430240	2107	2127	adenosine metabolism	T044	C1158592
27430240	2136	2145	treatment	T061	C0087111
27430240	2149	2155	sepsis	T047	C0243026